Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin Sensitivity

Study Description

Go to 

Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

Background:

Increases in obesity, diabetes, and some metabolic disorders may be linked to how much processed foods people eat. Researchers want to learn more about how processed foods affect metabolic health.

Objective:

To learn about how a processed versus unprocessed diet affects the body.

Eligibility:

Men ages 18-50 with stable weight and risk factors for diabetes

Design:

Participants will be screened over 3 visits. Screening includes:

• Medical history and physical exam
• Heart and blood tests
• Psychiatric questions
• Questions about eating, sleeping, and economic status
• Riding a stationary bike
• Trying a sample meal

Between screenings, participants will eat prepared meals. They will wear an accelerometer to measure physical activity. They will write down what foods they eat and monitor their weight.

Participants will have two 4-week stays in the clinic. They will:

• Eat a special diet
• Have activity and weight monitored
• Drink water and collect urine samples to measure how many calories they are burning
• Have resting energy expenditure measured with a clear hood over the head
• Have a scan to measure body fat and bone density using low-dose x-rays
• Have a scan on a table that slides into a metal cylinder in a strong magnetic field. They will get earplugs for the loud noises.
• Have an ultrasound test to measure blood vessels
• Have insulin and glucose infused into an arm vein. Blood will be taken over 10 hours through a plastic tube in the wrist. This will happen 4 times.
• Spend multiple 24-hour periods in a room that measures oxygen used and carbon dioxide produced.
• Give blood, urine and stool samples
• Answer questionnaires and do computer tasks

Condition or disease
Obesity

Detailed Description:

Nutrition science is beginning to place less emphasis on the nutrient composition of the diet and more emphasis on its comprising foods. A particular public health concern involves the consumption of foods that result from extensive industrial processing. Ultra-processed foods have become increasingly common and now contribute the majority of calories consumed in America. The rise in the prevalence of obesity, type 2 diabetes, and metabolic syndrome over the past several decades is believed to have been caused, in part, by the parallel increase in production, advertising, and consumption of ultra-processed foods. However, the metabolic effects of industrial processing per se, independent of diet calories or macronutrient composition, have not been carefully investigated in a controlled feeding study. Therefore, we will conduct an inpatient controlled feeding study in 20 overweight and obese adult men to investigate the changes in multi-organ insulin sensitivity and hepatic triglyceride content resulting from consuming two test diets for a pair of 3 week periods. The test diets will be implemented in a randomized, crossover design with each test diet following a 1 week run-in period of inpatient controlled feeding of a standard metabolic diet. The test diets will be matched for calories, macronutrient composition, sugar, fiber, and sodium, but one diet will be composed of ultra-processed foods whereas the other diet will be unprocessed foods. Multi-organ insulin sensitivity and hepatic triglyceride content will be measured at the end of each 1 week run-in period as well as at the end of each 3 week test diet period.

Study Design

Go to 

Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Observational
Estimated Enrollment :	200 participants
Observational Model:	Cohort
Time Perspective:	Cross-Sectional
Official Title:	Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin Sensitivity
Actual Study Start Date :	November 20, 2017
Estimated Primary Completion Date :	February 28, 2019
Estimated Study Completion Date :	February 28, 2020

Groups and Cohorts

Go to 

Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Healthy Volunteers; 20 overweight and obese adult men

Outcome Measures

Go to 

Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. To determine changes in hepatic insulin sensitivity following a 3-week ultra-processed diet as compared to following 3 weeks of an unprocessed diet matched for calories, macronutrient composition, sugar, fiber, and sodium. [ Time Frame: ongoing ]

Secondary Outcome Measures :

1. To determine changes in hepatic triglyceride content following a 3-week ultra-processed diet as compared to 3 weeks of an unprocessed diet matched for calories, macronutrient composition, sugar, fiber, and sodium [ Time Frame: ongoing ]

Eligibility Criteria

Go to 

Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years to 50 Years (Adult)
Sexes Eligible for Study:	Male
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

20 overweight and obese adult men

Criteria

• INCLUSION CRITERIA:

  1. Adult men, age 18-50 years
  2. Weight stable (< plus or minus 5 % over past 6 months)
  3. Body mass index (BMI) greater than or equal to 25 kg/m^2
  4. Plasma triglycerides > 150 mg/dl (Caucasian) or >140 mg/dl (African American)
  5. Homeostatic model of insulin resistance (HOMA-IR) > 2
  6. Able to complete daily bouts of stationary cycling at a moderate rate and intensity with a HR equal to or greater than 0.3x(220-age-HRrest)+HRrest but not exceeding 0.6x(220-age- HRrest)+HRrest and no signs of arrhythmia
  7. Written informed consent
  8. Willing to eat all the food provided in the study
  9. Willing to cease their habitual caffeine intake during the study, beginning one week prior to each inpatient admission

EXCLUSION CRITERIA:

1. Evidence of metabolic or cardiovascular disease, or disease that may influence metabolism (e.g. cancer, diabetes, thyroid disease)
2. Body weight >400 lbs. (weight limit of magnetic resonance spectroscopy gantry)
3. Taking any prescription medication or other drug that may influence metabolism (e.g. diet/weight-loss medication, asthma medication, blood pressure medication, psychiatric medications, corticosteroids, or other medications at the discretion of the PI and/or study team)
4. Hematocrit < 40%
5. Participating in a regular exercise program (> 2h/week of vigorous activity)
6. Caffeine consumption > 300 mg/day
7. Regular use of alcohol (> 2 drinks per day), tobacco (smoking or chewing) amphetamines, cocaine, heroin, or marijuana over past 6 months
8. Past or present history of eating disorder (including binge eating) or psychiatric disease, including claustrophobia since part of the protocol will involve being confined to a small room for whole-body indirect calorimetry and being in an MRI scanner for liver fat measures
9. Implants, devices, or foreign objects implanted in the body that interfere with the Magnetic Resonance procedures.
10. Volunteers with strict dietary concerns (e.g. vegetarian or kosher diet, food allergies)
11. Volunteers unwilling or unable to give informed consent
12. Non-English speakers due to unavailability of required questionnaires in other languages.

Contacts and Locations

Go to 

Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Contacts

Contact: Kevin Hall, Ph.D.	(301) 402-8248	kevinh@niddk.nih.gov

Locations

United States, Maryland
National Institutes of Health Clinical Center	Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

Principal Investigator:	Kevin Hall, Ph.D.	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

More Information

Go to 

Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Additional Information:

NIH Clinical Center Detailed Web Page 

Publications:

Monteiro CA, Moubarac JC, Cannon G, Ng SW, Popkin B. Ultra-processed products are becoming dominant in the global food system. Obes Rev. 2013 Nov;14 Suppl 2:21-8. doi: 10.1111/obr.12107. Review.

Tavares LF, Fonseca SC, Garcia Rosa ML, Yokoo EM. Relationship between ultra-processed foods and metabolic syndrome in adolescents from a Brazilian Family Doctor Program. Public Health Nutr. 2012 Jan;15(1):82-7. doi: 10.1017/S1368980011001571. Epub 2011 Jul 14.

Responsible Party:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:	NCT03189121 History of Changes
Other Study ID Numbers:	170107; 17-DK-0107
First Posted:	June 16, 2017
Last Update Posted:	May 23, 2018
Last Verified:	May 7, 2018

Studies a U.S. FDA-regulated Drug Product:		No
Studies a U.S. FDA-regulated Device Product:		No

Keywords provided by National Institutes of Health Clinical Center (CC) ( National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) ):

Metabolism; Macronutrients; Obesity; Energy Expenditure; Glucose

Additional relevant MeSH terms:

Insulin Resistance; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases	Insulin; Hypoglycemic Agents; Physiological Effects of Drugs